Biomedical Catalyst Fund

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients.

Invizius provides dialysis treatments and other extra-corporeal treatments for patients.

Vinehealth is a AI-driven platform providing support to improve the quality of life and survival of cancer patients.

SleepCogni is an award-winning British medical device start-up company at the forefront of personalised health technology for Insomnia.

MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.

Calcivis is a biotech company that focuses on unmet needs in dentistry.

Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.

Summit Therapeutics is a clinical-stage drug discovery and development company.

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK